期刊文献+

反相高效液相色谱法拆分西酞普兰对映异构体 被引量:9

RP-HPLC chiral separation of citalopram
原文传递
导出
摘要 目的:建立西酞普兰对映异构体的HPLC手性分析方法,用于草酸艾司西酞普兰光学纯度的分析测定。方法:采用不易变性的卵类粘蛋白键合硅胶(ES-OVM)为手性固定相,以乙腈-0.05 mol.L-1磷酸盐缓冲液(pH 7.0)(15︰85)为流动相,流速为1.0 mL.min-1,柱温30℃,检测波长240 nm,对西酞普兰对映异构体进行分离测定。结果:西酞普兰对映异构体在卵粘蛋白柱上实现了良好的分离,分离度为1.90。将该方法应用于手性拆分得到的草酸艾司西酞普兰的光学纯度测定,结果光学纯度大于97.9%。结论:该方法分离度与重现性好,可用于西酞普兰的光学纯度的分析测定及对拆分过程进行监测,结果可靠。 Objective :To establish an HPLC method to separate citalopram enantiomers on ovomucoid chiral column for optical purity detection of escitalopram oxalate. Methods: The mobile phase was recommended as acetonitrile -0. 05 mol ·L^-1 phosphate buffer(pH 7.0) (15:85)at a flow rate of 1.0 mL · min^-1. The column temperature was 30 ℃ and the detection wavelength was 240 nm. Results: Citalopram enantiomers were separated under the above conditions, the resolution between S - and R - citalopram was 1.90. The optical purity of escitalopram ox- alate was more than 97.9%. Conclusion: With good resolution and repeatability,the method can be reliably used for chiral separation of citalopram enantiomers, and determination of the optical purity of S - and R - citalopram sample.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第1期71-73,77,共4页 Chinese Journal of Pharmaceutical Analysis
基金 卫生行业科研专项:药物使用安全与输血安全相关技术与标准研究(200902008) 国家科技重大专项:药物微量杂质的检测和分离技术平台建设(2009ZX09313)
关键词 高效液相色谱 卵粘蛋白手性固定相 抗抑郁药 西酞普兰 对映异构体 异构体 手性分离 HPLC ovomucoid chiral solid phase antidepressant citalopram enantiomer isomer enantiomeric separation
  • 相关文献

参考文献7

二级参考文献51

  • 1杨雪梅,刘旭,严轶琛,徐江平.HPLC测定S-西酞普兰[J].第一军医大学学报,2004,24(6):716-717. 被引量:7
  • 2潘红娟,朱雪炎.氢溴酸西酞普兰的手性拆分及草酸依地普仑ee值检查[J].中国医药工业杂志,2004,35(8):484-485. 被引量:9
  • 3杜瑜,李焕德.抗抑郁新药西酞普兰的药代动力学[J].中国临床药理学杂志,2005,21(4):307-310. 被引量:21
  • 4Masilamani S,Ruppelt SC.Escitalopram (Lexapro) for depression[J].Am Fam Physician,2003,68(1 1):2235-6.
  • 5Croom KF,Plosker GL.Escitalopram:a pharmacoeconomic review of its use in depression[J].Pharmacoeconomics,2003,21 (16):1185-209.
  • 6Lepola UM,Loft H,Reines EH.Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care[J].Int Clin Psychopharmacol,2003,18(4):211-7.
  • 7Svensson S,Mansfield PR.Escitalopram:superior to citalopram or a chiral chimera[J]? Psychother Psychosom,2004,73(1):10-6.
  • 8Hyttel J,Bogeso KP,PerregaardJ,et al.The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer [J].JNeural Trans (Gen Sect),1992,88(2):157-60.
  • 9Kosel M,Eap CB,Amey M,et al.Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography[J].JChromatogr B Biomed Sci Appl,1998,719(1-2):234-8.
  • 10Sorbera LA, Revel L, Martin L, et al. Escitalopram oxalate [J]. Drugs Future, 2001, 26(2): 115-120.

共引文献31

同被引文献43

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部